Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Peringkat dalam Saham #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Harga Saham
$3.83
Kapitalisasi Pasar
$464.45M
Perubahan (1 hari)
-1.63%
Perubahan (1 tahun)
17.17%
Negara
TW
Perdagangan Gongwin Biopharm Holdings Co., Ltd. (6617)

Kategori

Riwayat harga saham Gongwin Biopharm Holdings Co., Ltd. (6617)
Harga penutupan tertinggi: $3.43 pada 2026-08-01

Harga penutupan terendah: $2.71 pada 2017-02-01
Riwayat harga saham Gongwin Biopharm Holdings Co., Ltd. dari 2017 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU